相关实验视频
Updated: May 5, 2026

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.5K
病例报告:严重脏干扰在一个非常早期发病的炎症性肠病病例
Enrico Drago1,2, Roberta Carfora1, Barbara Cafferata3
1Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genova, Italy.
Frontiers in immunology
|December 5, 2025
概括
非常早期发病的炎症性肠病 (VEO-IBD) 患者可能会因vedolizumab而患损伤. 这一病例突出了小儿科患者的急性管间炎 (TIN),该患者已成功接受类固醇治疗和重新开始使用vedolizumab.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
背景情况:
- 非常早期发病的炎症性肠病 (VEO-IBD) 往往呈现出耐治疗性.
- 维多利祖马布是一种有效的替代品,用于对TNF抗剂耐火的VEO-IBD.
- 在VEO-IBD中很少报告vedolizumab的脏并发症.
研究的目的:
- 在患有VEO-IBD的儿科患者中报告一例vedolizumab诱导的急性管间炎 (TIN).
- 描述这种并发症的临床表现,诊断结果和治疗方法.
- 强调无菌白细胞的潜在作用,作为早期指标.
主要方法:
- 一个11岁的女性患有VEO-IBD (性结肠炎表型) 的病例报告.
- 详细的临床病史,实验室调查,MRI和脏活检结果.
- 用葡萄糖皮质类药物治疗,暂时停止vedolizumab治疗,然后用类固醇预先治疗重新挑战.
主要成果:
- 患者患有急性TIN,肌水平升高,并且持续无菌白细胞尿.
- 脏活检证实了急性管道损伤和间歇性炎症.
- 类固醇治疗导致功能正常化; vedolizumab 重新挑战被容忍.
结论:
- 与vedolizumab相关的急性TIN是儿科VEO-IBD患者的潜在并发症.
- 及时诊断和使用皮质类固醇的治疗可以带来有利的结果.
- 无菌白细胞可能是vedolizumab诱导的毒性早期预警信号.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
1.5K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
Inflammatory Bowel Disease II: Crohn's Disease
1.6K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
Inflammatory Bowel Disease I: Introduction
42
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
42
Inflammatory Bowel Disease II: Ulcerative Colitis
34
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
34
Inflammatory Bowel Disease III: Crohn's Disease
35
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
35
Inflammatory Bowel Disease IV: Clinical Manifestations
33
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
33

